SRT3109 is primarily investigated for its potential therapeutic applications, particularly in the field of aging and age-related diseases. It is studied for its role as an activator of sirtuins, a group of proteins involved in cellular regulation and longevity. Research suggests it may help in managing metabolic disorders, improving insulin sensitivity, and reducing inflammation. Additionally, SRT3109 is explored for its potential in cardiovascular health by enhancing endothelial function and reducing oxidative stress. Its application in neurodegenerative diseases is also under investigation, with a focus on its ability to protect neurons and improve cognitive function.